Literature DB >> 32936508

Epigenetic Modification 6-Methyladenosine Can Impact the Potency and Specificity of siRNA.

Anna M Rydzik1,2, Dirk Gottschling1, Eric Simon1, Wioletta Skronska-Wasek1, Jörg F Rippmann1, Doris Riether1.   

Abstract

The introduction of N6-methyladenosine (m6 A) into siRNA targeting Factor VII impacts its potency in cells and has a significant influence on the selectivity of siRNA, including reduced off-targeting. These effects are dependent on the position of m6 A in the siRNA duplex, with some of the sequences identified as more potent and/or selective than their non-methylated counterpart. These findings broaden the repertoire of available chemical modifications for siRNA therapeutics and imply potential regulatory role of N6-methyladenosine in the RNAi pathways.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  antisense agents; epigenetics; methyladenosine; oligonucleotides; siRNA

Year:  2020        PMID: 32936508     DOI: 10.1002/cbic.202000551

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

Review 1.  Potential Use of CRISPR/Cas13 Machinery in Understanding Virus-Host Interaction.

Authors:  Mahmoud Bayoumi; Muhammad Munir
Journal:  Front Microbiol       Date:  2021-11-26       Impact factor: 5.640

Review 2.  Natural antisense transcripts as drug targets.

Authors:  Olga Khorkova; Jack Stahl; Aswathy Joji; Claude-Henry Volmar; Zane Zeier; Claes Wahlestedt
Journal:  Front Mol Biosci       Date:  2022-09-27

Review 3.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.